fda update on tirzepatide Speak up and share your perspective with the FDA. : r/tirzepatidecompound The FDA says the Zepbound

Many of the current challenges with GLP-1s are driven by persistent shortages, arbitrarily high costs of medications, providers inability to truly personalize treatments based on their individual patients responses, and a one-size-fits-all approach to dosing

But not every review glows

Their approved uses concern type 2 diabetes, cardiovascular and renal outcomes, chronic weight management, obstructive sleep apnea and noncirrhotic MASH

The Gallup poll, which was released this week, indicates that women nationwide have a higher obesity rate than men and utilize weight management medications more often

Together, we can explore these important steps and empower you on your path to wellness

That mechanism explains both the benefits and the common gastrointestinal side effects clinicians watch for